INTRODUCTION:Hypercholesterolaemia is estimated to cause 2.6 million deaths annually and one-third of the cases of ischaemic heart disease. In Argentina, the prevalence of hypercholesterolaemia increased between 2005 and 2013 from 27.9% to 29.8%. Only one out of four subjects with a self-reported diagnosis of coronary heart disease is taking statins. Since 2014, statins (simvastatin 20 mg) are part of the package of drugs provided free-of-charge for patients according to cardiovascular disease (CVD) risk stratification. The goal of this study is to test whether a complex intervention targeting physicians and pharmacist assistants improves treatment and control of hypercholesterolaemia among patients with moderate-to-high cardiovascular risk...
Introduction: The high prevalence of cardiovascular disease (CVD) in the Hispanic population of the ...
Aims To analyse the treatment and control of dyslipidaemia in patients at high and very high cardio...
Hypertension continues to be the leading cause of death and disability in the industrialized world, ...
Introduction Cardiovascular disease (CVD) accounts for approximately one-third of Argentina's deaths...
Background-—Control of cardiovascular disease (CVD) risk factors is suboptimal in Argentina, despite...
Background: The effective management of cardiovascular (CVD) prevention among the population with ex...
Background. Cardiovascular disease (CVD) is the primary cause of mortality and morbidity in Argentin...
Importance Despite extensive knowledge of hypertension treatment, the prevalence of uncontrolled hyp...
Funding: This study was supported by Fundación Hipercolesterolemia Familiar; Grant G03/181 Grant 08-...
Background: A recent cluster randomized trial evaluating a multicomponent intervention showed signif...
[Background] Maximal doses of potent statins are the basement of treatment of familial hypercholeste...
IntroductionThe high prevalence of cardiovascular disease (CVD) in the Hispanic population of the Un...
Background Routine general practice data collection can help identify patients at risk of cardiovasc...
Importance: Hypertension is highly prevalent in low- and middle-income countries, and it is an impor...
OBJECTIVE: To assess the effectiveness of a cholesterol-lowering intervention designed to facilitate...
Introduction: The high prevalence of cardiovascular disease (CVD) in the Hispanic population of the ...
Aims To analyse the treatment and control of dyslipidaemia in patients at high and very high cardio...
Hypertension continues to be the leading cause of death and disability in the industrialized world, ...
Introduction Cardiovascular disease (CVD) accounts for approximately one-third of Argentina's deaths...
Background-—Control of cardiovascular disease (CVD) risk factors is suboptimal in Argentina, despite...
Background: The effective management of cardiovascular (CVD) prevention among the population with ex...
Background. Cardiovascular disease (CVD) is the primary cause of mortality and morbidity in Argentin...
Importance Despite extensive knowledge of hypertension treatment, the prevalence of uncontrolled hyp...
Funding: This study was supported by Fundación Hipercolesterolemia Familiar; Grant G03/181 Grant 08-...
Background: A recent cluster randomized trial evaluating a multicomponent intervention showed signif...
[Background] Maximal doses of potent statins are the basement of treatment of familial hypercholeste...
IntroductionThe high prevalence of cardiovascular disease (CVD) in the Hispanic population of the Un...
Background Routine general practice data collection can help identify patients at risk of cardiovasc...
Importance: Hypertension is highly prevalent in low- and middle-income countries, and it is an impor...
OBJECTIVE: To assess the effectiveness of a cholesterol-lowering intervention designed to facilitate...
Introduction: The high prevalence of cardiovascular disease (CVD) in the Hispanic population of the ...
Aims To analyse the treatment and control of dyslipidaemia in patients at high and very high cardio...
Hypertension continues to be the leading cause of death and disability in the industrialized world, ...